Download FREE Report Sample
Download Free samplePropranolol, sold under the brand name Inderal among others, is a medication of the beta blocker class. It is used to treat high blood pressure, a number of types of irregular heart rate, thyrotoxicosis, capillary hemangiomas, performance anxiety, and essential tremors. It is used to prevent migraine headaches, and to prevent further heart problems in those with angina or previous heart attacks. It can be taken by mouth or by injection into a vein.
Propranolol Market contains market size and forecasts of Propranolol in global, including the following market information:
Global Propranolol Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Propranolol Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Propranolol companies in 2021 (%)
The global Propranolol market was valued at 397.2 million in 2021 and is projected to reach US$ 487.4 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Propranolol include Apotex, Teva, Atnas Pharma, AstraZeneca, Mylan, Novartis, Sanofi, Yabang Pharma and Sawai Seiyaku, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Propranolol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Propranolol Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Propranolol Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Global Propranolol Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Propranolol Market Segment Percentages, by Application, 2021 (%)
Arrhythmia
Hypertension
Others
Global Propranolol Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Propranolol Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Propranolol revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Propranolol revenues share in global market, 2021 (%)
Key companies Propranolol sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Propranolol sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Apotex
Teva
Atnas Pharma
AstraZeneca
Mylan
Novartis
Sanofi
Yabang Pharma
Sawai Seiyaku
ABZ-Pharma
Towa Yakuhin
Zydus Pharma
Nichi-Iko Pharmaceutical
Intas Pharma
IFET
Iqfarma
Zentiva
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy